Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Temozolomide (SCH 52365) in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer, Phase II

NCT00194766 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT00194766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00194766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Temozolomide (SCH 52365) in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer, Phase II
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2000
Completion date
December 31, 2006
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, soft tissue sarcoma